Cancer drug joins list of medicines in short supply

Download PDF Copy

Nov 14 2011

NewsGuard 100/100 Score

Los Angeles Times: Cancer Drug Doxil Joins Growing List Of Drugs In Short Supply
A crucial cancer drug has been in short supply since midsummer -; and its maker, Johnson & Johnson Inc., has not been able to remedy the situation since. The medicine, Doxil, is used to treat patients with ovarian cancer, multiple myeloma or Kaposi's sarcoma after first-line treatments have failed (Adams, 11/14).

This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Medical Condition News | Pharmaceutical News

Tags: Cancer, Drugs, Health Care, Kaposi's Sarcoma, Medicine, Multiple Myeloma, Myeloma, Ovarian Cancer, Research, Sarcoma

Comments (0)

Download PDF Copy

Suggested Reading

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

Researchers uncover key genes linked to DCIS progression

Researchers uncover key genes linked to DCIS progression

Air pollution linked to head and neck cancer risk

Air pollution linked to head and neck cancer risk

Study shows AI can predict prognosis in triple-negative breast cancer

Study shows AI can predict prognosis in triple-negative breast cancer

Innovative urine test could improve pancreatic cancer survival rates

Innovative urine test could improve pancreatic cancer survival rates

Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy

Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy

Golgi apparatus plays crucial role in enhancing T-cell function against cancer

Golgi apparatus plays crucial role in enhancing T-cell function against cancer

Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients

Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

AI-powered tool predicts gene activity in cancer cells from biopsy images